EFFECTS OF DUP 753 ON RENAL-FUNCTION OF NORMOTENSIVE AND SPONTANEOUSLY HYPERTENSIVE RATS

被引：53
作者：
FENOY, FJ [1 ]
MILICIC, I [1 ]
SMITH, RD [1 ]
WONG, PC [1 ]
TIMMERMANS, PBMWM [1 ]
ROMAN, R [1 ]
机构：
[1] MED COLL WISCONSIN,DEPT PHYSIOL,8701 WATERTOWN PLANK RD,MILWAUKEE,WI 53226
来源：
AMERICAN JOURNAL OF HYPERTENSION | 1991年 / 4卷 / 04期
关键词：
ANGIOTENSIN-II; HYPERTENSION; KIDNEY; RENAL HEMODYNAMICS; GLOMERULUS; SPONTANEOUSLY HYPERTENSIVE RATS; CONVERTING ENZYME INHIBITORS; CAPTOPRIL;
D O I：
10.1093/ajh/4.4.321S
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
This study examined the effects of a new, orally-active, nonpeptide angiotensin II (AII) receptor antagonist, 2-n-butyl-4-chloro-5-hydroxymethyl-1-[2'-(H-1-tetrazol-5-yl)biphenyl-4-yl)methyl] imidazole, DuP 753, on renal function of anesthetized, volume-expanded Wistar Kyoto (WKY) and spontaneously hypertensive rats (SHR), and in a group of euvolemic Munich-Wistar (MW) rats. Plasma renin activities were similar and averaged 4.4 +/- 0.7 and 4.3 +/- 1.4 ng AI/mL.h, respectively, in the SHR and WKY rats. In WKY rats (n = 15), DuP 753 (2 or 10 mg/kg, intravenously) had no effect on urine flow, sodium excretion, renal blood flow (RBF), or glomerular filtration rate (GFR). Fractional excretion of lithium (FELi) rose from 32 +/- 5 to 40 +/- 4% of the filtered load and arterial pressure decreased slightly from 129 +/- 2 to 122 +/- 2 mm Hg. In SHR (n = 9), urine flow fell 24%, and FELi and RBF increased by 27% and 30%, respectively, after 2 mg/kg DuP 753, but sodium excretion, GFR, and arterial pressure were not significantly altered. A higher dose of DuP 753 (10 mg/kg; n = 8) reduced arterial pressure, urine flow, and sodium excretion in the SHR. RBF increased 34%, while GFR and FELi were not significantly altered. Similar effects were seen in SHR (n = 11), given an equivalent antihypertensive dose of captopril (20 mg/kg). In euvolemic MW rats in which plasma renin activity was elevated to 18.8 +/- 3.3 ng AI/mL.h, DuP 753 (2 mg/kg, n = 7) increased RBF, urine flow, and sodium excretion, while mean arterial pressure and GFR were unaltered. These results indicate that blockade of AII receptors with DuP 753 has little effect on arterial pressure or renal function in volume-expanded WKY rats with normal PRA. In volume-expanded SHR, high doses of DuP 753 (10 mg/kg) and captopril (20 mg/kg) lower arterial pressure and renal vascular resistance with only small changes in sodium and water excretion.
引用
收藏
页码：S321 / S326
页数：6
相关论文
共 41 条
[1]  
Dzau V.J., Significance of the vascular renin-angiotensin pathway, Hypertension, 8, pp. 553-559, (1986)
[2]  
Mento P.F., Holt W.F., Murphy W.R., Wilkes B.M., Combined renin and converting enzyme inhibition in rats, Hypertension, 13, pp. 741-748, (1989)
[3]  
Smith S.G., Seymour A.A., Mazack E.K., Et al., Comparison of a new renin inhibitor and enalaprilat in renal hypertensive dogs, Hypertension, 9, pp. 150-156, (1987)
[4]  
Neisius D., Wood J.M., Antihypertensive effect of a renin inhibitor in marmosets with a segmental renal infarction, J Hypertens, 5, pp. 721-725, (1987)
[5]  
Huang W.-C., Ploth D.W., Bell P.D., Et al., Bilateral renal function responses to converting enzyme inhibitors in two-kidney, one-clip Goldblatt hypertensive rats, Hypertension, 3, pp. 285-293, (1981)
[6]  
Hall J.E., Guyton A.C., Smith M.J., Coleman T.G., Blood pressure and renal function during chronic changes in sodium intake: Role of angiotensin, Am J Physiol, 239, pp. F271-F280, (1980)
[7]  
Atlas S.A., Case D.B., Sealey J.E., Et al., Interruption of the renin-angiotensin system in hypertensive patients by captopril induces sustained reduction in aldosterone secretion, potassium retention and natriuresis, Hypertension, 1, pp. 274-280, (1979)
[8]  
Antonaccio M.J., Kerwin L., Pre-and postjunctional inhibition of vascular sympathetic function by captopril in SHR: Implications of vascular angiotensin II in hypertension and antihypertensiveactions of captopril, Hypertension, 3, pp. 154-162, (1981)
[9]  
Ando K., Fujita T., Ito Y., Et al., The role of renal hemodynamics in the antihypertensive effect of captopril, Am Heart J, 111, pp. 347-352, (1986)
[10]  
Kline R.L., Mercer P.F., Effect of captopril and hydralazine on arterial pressure-urinary output relationships in spontaneously hypertensive rats, Hypertension, 10, pp. 590-594, (1987)
12345